Thursday September 13

	\|			What’s new in research on bicuspid aortopathy?
				Simon Body, Bart Loeys
	08.30			The complex genetic architecture of bicuspid aortic valve related aortopathy, Bart Loeys
	08.38			Protein-altering and regulatory genetic variants near GATA4 implicated in BAV, Simon Body
	08.46			New insights in the genetics of aortopathy and BAV in Turner syndrome, Aline Verstraeten
	08.54			Circulating microRNAs in bicuspid aortopathy, Evaldas Girdauskas
	09.02			TGF-b/ENG ratio in bicuspid aortopathy, Alessandro Della Corte
	09.10			Discussion

	\|			What’s new in management of bicuspid aortopathy?
				Alessandro Della Corte, Hector Michelena
	09.35			Fluid dynamics simulations to understand BAV aortopathy mechanisms and risks, Luca Koechlin
	09.43			Searching for early biomechanically-driven indexes of aortic remodeling: where are we at? Emiliano Votta
	09.51			Advanced imaging biomarkers in bicuspid aortic valve disease surveillance, Malenka Bissell
	09.59			Gender-related differences in bicuspid aortopathy history and outcomes, Hector Michelena
	10.07			How does the current knowledge on BAV aortopathy impact valve repair? Alessandro Della Corte
	10.15			Phenotype-guided surgical treatment of bicuspid aortopathy, Ruggero De Paulis
	10.23			Discussion

	10.50			Coffee break
				Ask to expert I (Nagelmackers room – Level 2)
				Place of the laparoscopy in the management of the Type 2 endoleaks, Eric Allaire, Franco Grego, Jean-Paul Lavigne
				Short communication: unusual complication of IMA embolization for type 2 endoleaks, Arnaud Kerzmann

	\|			TAVI
				Patrizio Lancellotti, Thomas Modine
	11.20			Overview on ongoing randomized clinical trials in TAVI, Patrizio Lancellotti
	11.28			Is TAVR already arguable in low and moderate risk patients? Thomas Modine
	11.36			Aortic regurgitation after TAVI - Can we do better? Joëlle Kefer
	11.44			TAVI endocarditis, Bernard Iung
	11.52			Experience from CHU Liège, Belgium, Christophe Martinez, Mark Radermecker
	12.00			Perceval (suturless valve) indications at CHU Liège; a booster of the mini invasive aortic valve replacement program, Marc Radermecker
				Keynote lecture
	12.08			Aortic valve reconstruction using the Ozaki technique, when and in whom? Cesare Quarto
	12.18			Discussion

	12.30			Lunch Break

	\|			Keynote lecture
				Rodolphe Durieux
	13.30			Open reoperations for complications of endovascular aortic procedures: top of the iceberg? Nicholas Kouchoukos

	\|			Experts panels What is the aortic size threshold for TAA intervention?
				Natzi Sakalihasan
				Panelists: John Elefteriades, Nicholas Kouchoukos, Patrizio Lancellotti, Dianna Milewicz, Christoph Nienaber
	13.45			Should the criterion for surgical intervention for thoracic aortic aneurysm be moved “leftward” (earlier)? John Elefteriades
	13.55			Lesson learned from local experiences in Liège with type A dissection, Natzi Sakalihasan
	14.00			Discussion

	\|			The revised ascending aorta and aortic arch
				Jean-Olivier Defraigne, John Elefteriades, Nicholas Kouchoukos
	14.15			Genetic basis of thoracic aortic disease and impact of altered gene on patient management, Dianna Milewicz
	14.23			The z-score-misleading clinical science? John Elefteriades
	14.31			Arch variants, Tilo Kölbel
	14.39			Surgery of the aortic arch nowadays, Nicholas Kouchoukos
	14.47			Arch hybrid procedures are effective and durable for arch aneurysms, Colin Bicknell
	14.55			Endo-treatment of arch and ascending aorta, Tilo Kölbel
	15.03			Discussion

	15.30			Coffee break

	\|			Distal aortic dissection
				Bijan Modarai, Christoph Nienaber
	16.00			The conundrum about complicated and uncomplicated type B dissection - new concepts! Christoph Nienaber
	16.08			When is a dissection to be called chronic and why? Firas Mussa
	16.16			What is the role of tissue inflammation in dissection and how do we diagnose it? Natzi Sakalihasan
	16.24			How can imaging tell us about the plasticity of a dissection? Biomechanical modelling and PET/CT in type B aortic dissection: development of the Perth-Liege risk score for TBAD, Barry Doyle
	16.32			Temporal and morphological patterns predict outcome of endovascular repair in acute complicated type B aortic dissection, Rebecka Hultgren
	16.40			Critical aortic dissections: benefit of surgical creativity out of any guidelines, Parla Astarci
	16.48			Discussion

	\|			Distal aortic dissection
				Dianna Milewicz, Toru Suzuki
	17.10			The role of biomarkers in the setting of acute aortic syndrome? Toru Suzuki
	17.18			The integration of genetic testing in the work-up of a patient with aortic dissection, Bulat Ziganshin
	17.26			How to manage acute aortic dissection in pregnancy? John Elefteriades
	17.34			Discussion

	\|			Proximal aortic dissection
				Colin Bicknell, John Elefteriades
	18.00			The role of false lumen intervention to promote remodeling via induced thrombosis, Christoph Nienaber
	18.08			How much is arch reconstruction needed in type A aortic dissection? Ulrich Rosendahl
	18.16			Inching toward an endovascular solution for proximal dissection - will an Endo-Bentall see the light of day? Christoph Nienaber
	18.24			Open surgery for aortic dissections, Nimesh Desai
	18.32			Abdominal aortic open fenestration and other open surgical tricks: usefulness in type B dissections, Fabien Koskas
	18.40			Optimised management of type A aortic dissection with visceral malperfusion - concept to reconsider, Mathias Thielmann
	18.48			Short communication: the images behind intramural haematoma, Andreas Mitsis
	18.53			Discussion

	19.15			End of the sessions

	20.00			Official dinner